chlorpropamide has been researched along with Idiopathic Parkinson Disease in 3 studies
Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Majid, N | 1 |
| Siddiqi, MK | 1 |
| Hassan, MN | 1 |
| Malik, S | 1 |
| Khan, S | 1 |
| Khan, RH | 1 |
| BARRINGTON, PC | 1 |
| Ahmed, I | 1 |
| Ahmad, B | 1 |
| Hussain, MF | 1 |
1 trial available for chlorpropamide and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
The use of chlorpropamide in the treatment of Parkinsonism.
Topics: Adult; Aged; Chlorpropamide; Female; Humans; Male; Middle Aged; Parkinson Disease | 1968 |
2 other studies available for chlorpropamide and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Inhibition of primary and secondary nucleation alongwith disruption of amyloid fibrils and alleviation of associated cytotoxicity: A biophysical insight of a novel property of Chlorpropamide (an anti-diabetic drug).
Topics: Amyloid; Amyloidogenic Proteins; Amyloidosis; Chlorpropamide; Humans; Parkinson Disease | 2023 |
CHLORPROPAMIDE IN PARKINSON'S DISEASE.
Topics: Biomedical Research; Chlorpropamide; Drug Therapy; Humans; Parkinson Disease; Parkinsonian Disorders | 1964 |